MiRNAs with prognostic significance in multiple myeloma
Open Access
- 1 August 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (33) , e16711
Abstract
Background: Multiple myeloma (MM) is a clonal plasma cell malignancy associated with hypercalcemia, bone lesions, and renal failure. The prognostic significance of the mutation of miRNAs, one kind of small noncoding RNA molecules that can modulate gene expression, should be confirmed in non-Hodgkin lymphomas (NHL). This study aimed to identify the prognostic value of miRNAs in patients with MM. Methods: A meta-analysis was performed to estimate the pooled hazard ratios and their corresponding 95% confidence intervals for the associations between levels of miRNA expression (predictive factors) and outcomes in patients with MM. We systematically searched the PubMed, Web of Science, and China National Knowledge Infrastructure databases (final search conducted January 1, 2018) to identify eligible studies. Eligible studies were included by certain inclusion and exclusion criteria, whose quality was assessed by Newcastle-Ottawa Scale. Results: After performing the literature search and review, 10 relevant studies, including 1214 cases, were identified. The results of our meta-analysis revealed that upregulated miR-92a level and downregulated miR-16, miR-25, miR-744, miR-15a, let-7e, and miR-19b expression were associated with poor prognosis in MM. Conclusions: This study identified miRNAs could serve as potential prognostic biomarkers in MM. Given the limited research available, the clinical application of these findings has yet to be verified.Keywords
This publication has 50 references indexed in Scilit:
- Downregulation of miRNA‑15a and miRNA‑16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expressionOncology Letters, 2017
- MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysisOncotarget, 2015
- Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16Oncotarget, 2015
- Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinomaMolecular Cancer, 2015
- Low serum miR‐19a expression as a novel poor prognostic indicator in multiple myelomaInternational Journal of Cancer, 2014
- Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1Blood, 2011
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosisCancer Science, 2010
- An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaBlood, 2008
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002